Kexun Li, Simiao Lu, Changding Li, Jie Mao, Huan Zhang, Kangning Wang, Guangyuan Liu, Yongtao Han, Lin Peng, Xuefeng Leng
{"title":"Evaluating the role of BMI in survival and complications in older esophageal squamous cell carcinoma following esophagectomy.","authors":"Kexun Li, Simiao Lu, Changding Li, Jie Mao, Huan Zhang, Kangning Wang, Guangyuan Liu, Yongtao Han, Lin Peng, Xuefeng Leng","doi":"10.3389/or.2026.1757530","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To evaluate the impact of Body Mass Index (BMI) on survival and postoperative complications in older patients with esophageal squamous cell carcinoma (ESCC) following esophagectomy, we designed this study.</p><p><strong>Materials and methods: </strong>We retrospectively analyzed 469 patients aged ≥70 years with thoracic ESCC who underwent esophagectomy at Sichuan Cancer Hospital (May 2016-August 2021). Patients were grouped by WHO BMI categories: underweight (<18.5 kg/m<sup>2</sup>), normal (18.5-24.9 kg/m<sup>2</sup>), and overweight/obese (≥25 kg/m<sup>2</sup>). Primary outcomes were overall survival (OS) and disease-free survival (DFS); secondary outcomes included Clavien-Dindo grade III-IV complications. Kaplan-Meier, Cox models, and restricted cubic splines (RCS) were used.</p><p><strong>Results: </strong>Median follow-up was 47.5 months; R0 resection was achieved in 96.4%. BMI distribution: 7.3% low, 76.8% normal, 16.0% high. Median OS was 44.9 months overall, with no significant OS or DFS differences among BMI groups. RCS demonstrated a significant U-shaped association between continuous BMI and survival: protective ranges were approximately 21.9-27.0 kg/m<sup>2</sup> for OS (P non-linearity = 0.014) and 20.2-27.2 kg/m<sup>2</sup> for DFS (P non-linearity = 0.033).</p><p><strong>Conclusion: </strong>In elderly ESCC patients after esophagectomy, BMI does not independently influence OS or DFS, though low BMI is associated with specific serious complications. Perioperative optimization-particularly nutritional support for underweight patients-remains essential.</p>","PeriodicalId":19487,"journal":{"name":"Oncology Reviews","volume":"20 ","pages":"1757530"},"PeriodicalIF":4.0000,"publicationDate":"2026-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12968272/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/or.2026.1757530","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To evaluate the impact of Body Mass Index (BMI) on survival and postoperative complications in older patients with esophageal squamous cell carcinoma (ESCC) following esophagectomy, we designed this study.
Materials and methods: We retrospectively analyzed 469 patients aged ≥70 years with thoracic ESCC who underwent esophagectomy at Sichuan Cancer Hospital (May 2016-August 2021). Patients were grouped by WHO BMI categories: underweight (<18.5 kg/m2), normal (18.5-24.9 kg/m2), and overweight/obese (≥25 kg/m2). Primary outcomes were overall survival (OS) and disease-free survival (DFS); secondary outcomes included Clavien-Dindo grade III-IV complications. Kaplan-Meier, Cox models, and restricted cubic splines (RCS) were used.
Results: Median follow-up was 47.5 months; R0 resection was achieved in 96.4%. BMI distribution: 7.3% low, 76.8% normal, 16.0% high. Median OS was 44.9 months overall, with no significant OS or DFS differences among BMI groups. RCS demonstrated a significant U-shaped association between continuous BMI and survival: protective ranges were approximately 21.9-27.0 kg/m2 for OS (P non-linearity = 0.014) and 20.2-27.2 kg/m2 for DFS (P non-linearity = 0.033).
Conclusion: In elderly ESCC patients after esophagectomy, BMI does not independently influence OS or DFS, though low BMI is associated with specific serious complications. Perioperative optimization-particularly nutritional support for underweight patients-remains essential.
期刊介绍:
Oncology Reviews is a quarterly peer-reviewed, international journal that publishes authoritative state-of-the-art reviews on preclinical and clinical aspects of oncology. The journal will provide up-to-date information on the latest achievements in different fields of oncology for both practising clinicians and basic researchers. Oncology Reviews aims at being international in scope and readership, as reflected also by its Editorial Board, gathering the world leading experts in both pre-clinical research and everyday clinical practice. The journal is open for publication of supplements, monothematic issues and for publishing abstracts of scientific meetings; conditions can be obtained from the Editor-in-Chief or the publisher.